Back to Archive

SensUs 2019

Rheumatic Disease

Biomarker: Adalimumab

The Theme

SensUs 2019 challenged student teams to develop innovative biosensing systems for the measurement of adalimumab, a biological drug that is prescribed to patients suffering from rheumatoid arthritis (RA). RA affects around 1% of the world population. Measurement of adalimumab concentrations will enable more efficient and effective management of the disease.

Results

Innovation Award

Translation Potential Award

Analytical Performance Award

Public Inspiration Award

The Teams

The Organization

SensUs is organized for students by students. The Organization of SensUs consists of motivated students from different fields at the Eindhoven University of Technology, the Netherlands. Each member joined for a different goal, but all members want to contribute to the future of health. Our organization has been founded by professor Menno Prins.

prof. dr. ir. Menno Prins

prof. dr. ir. Menno Prins

FOUNDER AND GUIDE

Kirsten Peeters

Kirsten Peeters

Chair

Aaron Saam

Aaron Saam

Vice-Chair

Yannick Leurs

Yannick Leurs

Secretary

Maria Pop

Maria Pop

Treasurer

Rutger van Doorslaer

Rutger van Doorslaer

Events

Judith Hoekstra

Judith Hoekstra

Events

Julia van der Vleuten

Julia van der Vleuten

Events

Maaike Konig

Maaike Konig

Events

Roderick Haarselhorst

Roderick Haarselhorst

External Relations

Teun van Acker

Teun van Acker

External Relations

Cecile van Riele

Cecile van Riele

External Relations

Vincent Eurlings

Vincent Eurlings

External Relations

Isabel van der Steenhoven

Isabel van der Steenhoven

Public Relations

Jorrit Baartman

Jorrit Baartman

Public Relations

Julia Geschiere

Julia Geschiere

Public Relations

Suzanne Ansems

Suzanne Ansems

Public Relations

H

Hanna Merényi

Technology

Jojanne van Leeuwen

Jojanne van Leeuwen

Technology

Marloes Coolen

Marloes Coolen

Technology

Myrthe Kater

Myrthe Kater

Technology